FDA recall D-1292-2019
D.B.P. Distribution · Class I · drug
Product
Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020
Reason for recall
Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.
Distribution
Nationwide.
Key facts
- Status
- Terminated
- Initiation date
- 2019-04-23
- Report date
- 2019-05-22
- Termination date
- 2023-03-07
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Chatsworth, CA, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1292-2019